Lux Bio seeks US & European marketing nod for oral voclosporin to treat non-infectious uveitis
Saturday, February 06, 2010 12:00 IST New Jersey
Lux Biosciences, Inc. announced its submission of simultaneous regulatory filings to both the US Food and Drug Administration (FDA) and European Medicines Agency (EMA)
